WuXi PharmaTech Announces Expanded Agreement with Merck & Co., Inc.

2006-12-07 16:55 1494

SHANGHAI, China, Dec. 7 /Xinhua-PRNewswire/ -- WuXi PharmaTech Co. Ltd.,

China’s leading pharmaceutical R&D service company, announced today that

Merck & Co., Inc., of Whitehouse Station, NJ, USA, has agreed to extend and

expand an agreement through which WuXi provides a variety of chemistry-

related R&D services.

(Logo: )

The existing agreement between the two companies was signed in 2003. The

new expanded agreement, extended till 2010, offers additional opportunities

for collaboration, and substantially increases the number of full-time WuXi

scientists assisting Merck. A broader range of functional WuXi services

including synthesis, process research, and medicinal chemistry, will also be

utilized. Merck is one of the largest pharmaceutical companies to seek WuXi’

s services. Financial terms were not disclosed.

"This is a win-win opportunity for both sides,” says Dr. Ge Li, Chairman

and CEO of WuXi PharmaTech. “Our partnership with Merck helps us gain world

class experience, and at the same time helps Merck better deploy their R&D

resources. This agreement, the result of WuXi’s sustained high performance

on Merck projects, contributes greatly to our strategic target of becoming a

first-class fully integrated R&D service company,” continued Dr. Li.

About WuXi PharmaTech

WuXi PharmaTech Co., Ltd. is China’s leading pharmaceutical R&D and

manufacturing services provider. It provides its collaborative partners with

a broad and value-added service portfolio ranging from custom synthesis,

library production, lead generation and optimization, in vivo and in vitro

ADMET profiling, and bioanalytical services, to chemistry process development

and industrial manufacturing. For more information please visit .

About Merck

Merck & Co., Inc. is a global research-driven pharmaceutical company

dedicated to putting patients first. Established in 1891, Merck currently

discovers, develops, manufactures and markets vaccines and medicines to

address unmet medical needs. The Company devotes extensive efforts to

increase access to medicines through far-reaching programs that not only

donate Merck medicines but help deliver them to the people who need them.

Merck also publishes unbiased health information as a not-for-profit

service. For more information, visit .

Source: WuXi PharmaTech Co., Ltd.
Related Stocks: